Updated Analysis of a Phase 1, Open-Label Study of LCAR-B38M, a Chimeric Antigen Receptor T Cell Therapy Directed Against B-Cell Maturation Antigen, in Patients with Relapsed/Refractory Multiple Myeloma

被引：27

作者：

Zhao, Wan-Hong ^{[1
]}

Liu, Jie ^{[1
]}

Wang, Bai-Yan ^{[1
]}

Chen, Yin-Xia ^{[1
]}

Cao, Xing-Mei ^{[1
]}

Yang, Yun ^{[1
]}

Zhang, Yi-Lin ^{[1
]}

Wang, Fang-Xia ^{[2
]}

Zhang, Peng-Yu ^{[1
]}

Lei, Bo ^{[1
]}

Gu, Liu-Fang ^{[1
]}

Wang, Jian-Li ^{[1
]}

Yang, Nan ^{[1
]}

Zhang, Ru ^{[1
]}

Zhang, Hui ^{[1
]}

Shen, Ying ^{[1
]}

Bai, Ju ^{[1
]}

Xu, Yan ^{[1
]}

Wang, Xu-Geng ^{[1
]}

Zhang, Rui-Li ^{[1
]}

Wei, Li-Li ^{[1
]}

Li, Zong-Fang ^{[3
]}

Li, Zhen-Zhen ^{[3
]}

Geng, Yan ^{[4
]}

He, Qian ^{[4
]}

Zhuang, Qiu-Chuan ^{[5
]}

Fan, Frank Xiao-Hu ^{[5
]}

He, Ai-Li ^{[1
,3
]}

Zhang, Wang-Gang ^{[1
]}

机构：

[1] Xi An Jiao Tong Univ, Dept Hematol, Affiliated Hosp 2, Xian, Shaanxi, Peoples R China

[2] Xi An Jiao Tong Univ, Affiliated Hosp 2, Xian, Shaanxi, Peoples R China

[3] Xi An Jiao Tong Univ, Natl Local Joint Engn Res Ctr Biodiagnost & Bioth, Affiliated Hosp 2, Xian, Shaanxi, Peoples R China

[4] Xi An Jiao Tong Univ, Dept Clin Lab, Affiliated Hosp 2, Xian, Shaanxi, Peoples R China

[5] Nanjing Legend Biotech, Nanjing, Jiangsu, Peoples R China

来源：

BLOOD | 2018年 / 132卷

关键词：

D O I：

10.1182/blood-2018-99-110548

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

955

引用

页数：4

共 50 条

[21] Quantification of B-cell maturation antigen, a target for novel chimeric antigen receptor T-cell therapy in Myeloma
Salem, Dalia A.
Maric, Irina
Yuan, Constance M.
Liewehr, David J.
Venzon, David J.
Kochenderfer, James
Stetler-Stevenson, Maryalice
LEUKEMIA RESEARCH, 2018, 71 : 106 - 111
[22] CAR T-Cell Therapy Against B-Cell Maturation Antigen in Multiple Myeloma
Cohen, Adam D.
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (12) : 804 - 806
[23] A Novel Composite Endpoint of Toxicity- and Progression-Free Survival after B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma
Mohty, Razan
Junmin, Whiting
Saha, Aditi
Kim, Jongphil
Nishihori, Taiga
De Avila, Gabriel
Corallo, Salvatore
Dam, Marian
Marin, Jessica
Liu, Hien
Mokhtari, Sepideh
Jain, Michael D.
Perna, Fabiana
Blue, Brandon
Grajales-Cruz, Ariel F.
Castaneda, Omar
Shain, Kenneth
Baz, Rachid
Freeman, Ciara Louise L.
Alsina, Melissa
Locke, Frederick L.
Hansen, Doris K.
Lazaryan, Aleksandr
BLOOD, 2023, 142
[24] Chimeric antigen receptor T cell targeting B cell maturation antigen immunotherapy is promising for multiple myeloma
Ma, Tiantian
Shi, Jing
Liu, Huasheng
ANNALS OF HEMATOLOGY, 2019, 98 (04) : 813 - 822
[25] Chimeric antigen receptor T cell targeting B cell maturation antigen immunotherapy is promising for multiple myeloma
Tiantian Ma
Jing Shi
Huasheng Liu
Annals of Hematology, 2019, 98 : 813 - 822
[26] Infusion of chimeric antigen receptor T cells against dual targets of CD19 and B-cell maturation antigen for the treatment of refractory multiple myeloma
Tang, Fang
Lu, Yin
Ge, Yongqin
Shang, Jingjing
Zhu, Xiaming
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (01)
[27] Chimeric Antigen Receptor T-Cell Therapy in Elderly Patients with Relapsed or Refractory Large B-Cell Lymphoma: A Multicenter Study
Tun, Aung M.
Patel, Romil
St-Pierre, Frederique
Ouchveridze, Evguenia
Niu, Alex
Obasi, Jennifer
Rosenthal, Allison C.
Pophali, Priyanka A.
Fenske, Timothy S.
Karmali, Reem
Ahmed, Sairah
Johnston, Patrick B.
BLOOD, 2023, 142
[28] A Systematic Meta-Analysis of Cytokine Release Syndrome Incidence in B-Cell Maturation Antigen-Targeting Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies for Patients with Relapsed and/or Refractory Multiple Myeloma
Sharma, Sheena
Wang, Diane
Lon, Hoi-Kei
Soltantabar, Pooneh
Viqueira, Andrea
Czibere, Akos
Hickman, Anne
White, Jane Liang
Elmeliegy, Mohamed
BLOOD, 2022, 140 : 10036 - 10038
[29] Incidence, clinical characteristics and prognosis of tumor lysis syndrome following B-cell maturation antigen-targeted chimeric antigen receptor-T cell therapy in relapsed/refractory multiple myeloma
Zhang, Qiqi
Zu, Cheng
Jing, Ruirui
Feng, Youqin
Zhang, Yanlei
Zhang, Mingming
Lv, Yuqi
Cui, Jiazhen
Zhou, Linhui
Meng, Ye
Wang, Linqin
Cen, Zenan
Chang, Alex H. H.
Hu, Yongxian
Huang, He
FRONTIERS IN IMMUNOLOGY, 2023, 14
[30] Anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy for the Treatment of AL Amyloidosis and Concurrent Relapsed/Refractory Multiple Myeloma: Preliminary Efficacy and Safety
Das, Saurav
Ailawadhi, Sikander
Sher, Taimur
Roy, Vivek
Fernandez, Andre
Parrondo, Ricardo D.
CURRENT ONCOLOGY, 2023, 30 (11) : 9627 - 9633

← 1 2 3 4 5 →